Keywords
Oryz-aspergillus enzyme and pancreatin tablets
Reflux esophagitis
Functional dyspepsia
Submitted : 2024-02-27
Accepted : 2024-03-13
Published : 2024-03-28
Abstract
Objective: To investigate the therapeutic effect of Biling Weitong Granules combined with oryz-aspergillus enzyme and pancreatin tablets on patients with reflux esophagitis with functional dyspepsia. Methods: Sixty patients diagnosed with reflux esophagitis with functional dyspepsia who were admitted to the Affiliated Hospital of Hebei University between June 2020 and June 2023 were selected and divided into two groups: the control group and the observation group, each consisting of 30 cases. The control group received oryz-aspergillus enzyme and pancreatin tablets only, while the observation group received Biling Weitong Granules in addition to the tablets. The clinical efficacy, Chinese medicine syndrome points, esophageal kinetic indexes, gastrointestinal hormone levels, and therapeutic safety of both groups were evaluated. Results: The total efficiency of the observation group reached 93.33%, significantly higher than the 73.33% of the control group (P < 0.05). After treatment, patients in the observation group exhibited significantly lower scores for Chinese medicine symptoms such as early satiety, belching, abdominal distension, abdominal pain, and loss of appetite compared to the control group (P < 0.05). Furthermore, the observation group showed significantly higher upper esophageal sphincter pressure, lower esophageal sphincter pressure, and distal esophageal contraction scores compared to the control group (P < 0.05). Additionally, levels of gastric motility hormone, vasoactive intestinal peptide, and gastrin were significantly higher in the observation group compared to the control group (P < 0.05). Throughout the treatment period, there was no significant difference in the incidence of adverse reactions between the two groups, indicating comparable safety of the two treatment modalities (P > 0.05). Conclusion: The combination of Biling Weitong Granules with oryz-aspergillus enzyme and pancreatin tablets demonstrates significant efficacy in the treatment of reflux esophagitis with functional dyspepsia, with a better safety profile. This finding warrants further clinical promotion.
References
Li M, Zhang W, Guo L, et al., 2021, Efficacy and Safety of Vonoprazan versus PPIs in Treating Reflux Esophagitis: A Meta-Analysis. Chinese General Practice, 24(6): 712–717.
Liu Z, Liang S, Qiu L, et al., 2019, A Randomized Controlled Study on the Treatment of Liver Cirrhosis with Reflux Esophagitis Using Oryz-Aspergillus Enzyme and Pancreatin Tablets. Modern Digestion & Intervention, 2019(A02): 2606–2607.
Li M, Wang X, Niu M, et al., 2021, Efficacy of Rabeprazole and Moxapride Combined with Aspergillus Oryzae Trypsin in Treatment of Reflex Esophagitis with Functional Dyspepsia. Chinese Journal of New Drugs and Clinical Remedies, 2021(7): 515–519.
Wang L-H, Wang F-L, Li J, et al., 2021, Thought of Syndrome Differentiation and Countermeasures in Chinese Medical Treatment of Functional Dyspepsia. China Journal of Traditional Chinese Medicine and Pharmacy, 36(9): 5368–5371.
Qu Y-D, Wu S-S, Zhang N-Y, et al., 2022, Clinical Observation of Biling Weitong Granule in the Treatment of Functional Dyspepsia and Epigastric Pain Syndrome in College Students. World Journal of Integrated Traditional and Western Medicine, 17(1): 131–136. https://doi.org/10.13935/j.cnki.sjzx.220126
Mao X, Guo S, Ni W, et al., 2020, Effects of Qizhi Weitong Granules on Gastric Sensitivity and Mental State of Functional Dyspepsia Model Rats. Journal of Traditional Chinese Medicine, 61(22): 1996–2003. https://doi.org/10.13288/j.11-2166/r.2020.22.016
Bai Z, Gao Z, 2021, The Efficacy and Safety Observation of the Combination of Biling Weitong Granules and Pantoprazole Quadruple Therapy in the Treatment of Patients with Chronic Gastritis Complicated with Helicobacter pylori Infection. Guizhou Medical Journal, 45(11): 1716–1717.
Hong S, Huang J, Xu S, 2021, Effect of Biling Weitong Granules Combined with Quadruple Therapy on Chronic Atrophic Gastritis with Positive Helicobacter pylori Infection. China Medical Herald, 18(29): 122–125.
Wang Z, Ye B, 2019, Experience of Ye Bai’s Application of Kaijinsan in the Treatment of Functional Dyspepsia. Journal of Traditional Chinese Medicine, 34(1): 30–32.
Zhong Z, Huang J, Ye Z, et al., 2020, A Study on the Treatment Rules of Professor Huang Suiping’s Functional Dyspepsia (FD) Based on Data Mining Technology. Lishizhen Medicine and Materia Medica Research, 2020(3): 753–755.
Zhang H, Li J, 2020, Li Julin’s Experience in Recovering Functional Dyspepsia Based on Recovery of Airlift. Journal of Sichuan of Traditional Chinese Medicine, 38(2): 4–7.